CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,000 | +20.0% | 1,394 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 1,394 | -6.6% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 1,493 | -1.3% | 0.00% | – |
| Q3 2021 | $5,000 | -16.7% | 1,512 | +1.4% | 0.00% | – |
| Q2 2021 | $6,000 | -25.0% | 1,491 | -1.4% | 0.00% | – |
| Q1 2021 | $8,000 | -38.5% | 1,512 | +51.2% | 0.00% | – |
| Q4 2020 | $13,000 | +30.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $10,000 | +233.3% | 1,000 | +400.0% | 0.00% | – |
| Q4 2018 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |